DELFI Diagnostics, Inc.

DELFI Diagnostics is a biotech company focused on saving lives through early cancer detection with blood-based tests. Their platform analyzes cell-free DNA fragmentation patterns using genome-wide sequencing and machine learning to noninvasively detect and localize multiple cancer types from a routine blood draw. DELFI develops tests for screening, diagnosis, and disease monitoring and advances validation through clinical collaborations and trials. The company’s mission is to deliver sensitive, scalable liquid‑biopsy solutions that enable earlier intervention and better outcomes for patients.